The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Padma-Nathan and colleagues reported in a multicentered, placebo-controlled, prospective study of prophylactic sildenafil dosed nightly beginning 4 weeks after BNSRP and continuing for 36 weeks that patients taking prophylactic sildenafil had a 27% return of erectile function compared with only 4% in the placebo group (p <0.05) (Padma-Nathan et al 2008).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Padma-Nathan et al 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1999) · doi:10.1016/s0090-4295(99)00099-0 · Cited by 1,051
Sildenafil (Viagra) Induces Neurogenesis and Promotes Functional Recovery After Stroke in Rats
Zhang, R., Wang, Y., Zhang, L., Zhang, Z., Tsang, W., Lu, M., Zhang, L., & Chopp, M. (2002) · Stroke · doi:10.1161/01.str.0000034399.95249.59 · Cited by 383
Dubbelman, Y. D., Dohle, G. R., & Schröder, F. H. (2006) · European Urology · doi:10.1016/j.eururo.2006.06.009 · Cited by 222
Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma
Robinson, J. W., Moritz, S., & Fung, T. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03030-4 · Cited by 202
Research works printed but not linked: 26
- McCullough AR . Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am 2001; 28: 613–627. · DOI
- Walsh PC, Partin AW, Epstein JI . Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994; 152: 1831–1836. · DOI · Paper page
- Klein LT, Miller MI, Buttyan R, Raffo AJ, Burchard M, Devris G et al. Apoptosis in the rat penis after penile denervation. J Urol 1997; 158: 626–630. · DOI
- User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT . Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003; 169: 1175–1179. · DOI · Paper page
- Zippe CD, Raina R, Thukral M, Lakin MM, Klein EA, Agarwal A . Management of erectile dysfunction following radical prostatectomy. Curr Urol Rep 2001; 2: 495–503. · DOI
- Meuleman EJ, Mulders PF . Erectile function after radical prostatectomy: a review. Eur Urol 2003; 43: 95–102. · DOI
- Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997; 158: 1408–1410. · DOI · Paper page
- Schwartz EJ, Wong P, Graydon RJ . Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004; 171: 771–774. · DOI
- Montorsi F, Maga T, Strambi LF, Salonia A, Barbieri L, Scattoni V et al. Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 2000; 56: 906–911. · DOI
- Rabbani F, Patel M, Scardino PT . Time course of recovery of potency after bilateral nerve sparing radical prostatectomy. J Urol 2004; 171 (Suppl 4): 310. · DOI
- Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A . The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830. · DOI · Paper page
- Hong EK, Lepor H, McCullough AR . Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy (RRP). Int J Impot Res 1999; 11: S15–S22. · DOI
- Catalona WJ, Ramos CG, Carvalhal GF . Contemporary results of anatomic radical prostatectomy. CA Cancer J Clin 1999; 49: 282–296. · DOI
- Catalona WJ, Carvalhal GF, Mager DE, Smith DS . Potency, continence and complication rates in 1870 consecutive radical retropubic prostatectomies. J Urol 1999; 162: 433–438. · DOI · Paper page
- Fowler Jr FJ, Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J . Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology 1995; 45: 1007–1013. · DOI · Paper page
- Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J . Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990; 170: 843–850. · DOI · Paper page
- Bush PA, Aronson WJ, Buga GM, Rajfer J, Ignarro LJ . Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. J Urol 1992; 147: 1650–1655. · DOI
- Azadzoi KM, Kim N, Brown ML, Goldstein I, Cohen RA, Saenz de Tejada I . Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. J Urol 1992; 147: 220–225. · DOI
- Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I . Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest 1993; 91: 437–442. · DOI · Paper page
- Moreland RB . Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998; 10: 113–120. · DOI
- Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47–52.
- Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM . Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998; 159: 2164–2171. · DOI · Paper page
- Katz SD . Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure. Congest Heart Fail 2003; 9: 9–15. · DOI
- Katz SD, Balidemaj K, Homma S, Wu H, Wang J, Maybaum S . Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. J Am Coll Cardiol 2000; 36: 845–851. · DOI · Paper page
- Desouza C, Parulkar A, Lumpkin D, Akers D, Fonseca VA . Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care 2002; 25: 1336–1339. · DOI
- Nakamizo T, Kawamata J, Yoshida K, Kawai Y, Kanki R, Sawada H et al. Phosphodiesterase inhibitors are neuroprotective to cultured spinal motor neurons. J Neurosci Res 2003; 71: 485–495. · DOI
Cited by
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation
Hatzimouratidis, K., Amar, E., Eardley, I., Giuliano, F., Hatzichristou, D., Montorsi, F., Vardi, Y., & Wespes, E. (2010) · European Urology · doi:10.1016/j.eururo.2010.02.020 · Cited by 1,223
Self-citationYafi, F. A., Jenkins, L., Albersen, M., Corona, G., Isidori, A. M., Goldfarb, S., Maggi, M., Nelson, C. J., Parish, S., Salonia, A., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.3 · Cited by 853
Tadalafil in the treatment of erectile dysfunction
Coward, R., & Carson, C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3336 · Cited by 138
Psychosocial perspectives on sexual recovery after prostate cancer treatment
Walker, L. M., Wassersug, R. J., & Robinson, J. W. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.29 · Cited by 69
Wang, X., Wang, X., Liu, T., He, Q., Wang, Y., & Zhang, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091327 · Cited by 51
Metadata
- Authors
- Padma-Nathan, H., McCullough, A. R., Levine, L. A., Lipshultz, L. I., Siegel, R., Montorsi, F., Giuliano, F., Brock, G., & on behalf of the Study Group
- Venue
- International Journal of Impotence Research
- Published
- 2008-07-24
- Volume
- 20
- Issue
- 5
- Pages
- 479-486
- ISSN
- 0955-9930
- 1476-5489
- Cited by
- 234
- References
- 4
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
